Al Sirona (Luxembourg) Acquisition / Zentiva Group
2018 · Acquisition/Merger · $2.4B · Complete
Outcome Score
48
Mixed — partial payoff, real shortfalls.
Advent International, through its acquisition vehicle Al Sirona (Luxembourg) Acquisition S.à r.l., acquired generics maker Zentiva from Sanofi for an enterprise value of EUR 1.9 billion (approximately $2.35 billion). The all-cash private-equity transaction carved out Sanofi's European generics business into a standalone platform. Exclusive negotiations were announced in April 2018, the sale-and-purchase agreement was concluded on June 28, 2018, and the transaction completed effective September 30, 2018.